Journal in the field and provides all-inclusive access to the critical pillars of human gene therapy: research, methods, and clinical applications. Recent clinical trials utilizing high doses of adeno ...
No vector-related safety concerns have been noted in any patient in the study who received gene-modified hematopoietic stem cells; specifically, no leukoproliferative or myelodysplastic complications, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results